The thoroughly updated and revised third edition of Management of Prostate Cancer provides concise and authoritative guidance to today's best therapeutic regimens for the diagnosis and treatment of prostate cancer.? Highlighting the latest major advances in the field, the book includes chapters on the most controversial areas of prostate cancer screening, chemoprevention, and active surveillance; updated chapters on genetic risk and progression, biopsy schemes, treatment of complications, and comparative treatment outcomes for surgery; and new chapters on risk factors, new markers, nomograms, and focal therapy. This volume also features overviews of new and emerging drugs and treatment paradigms for castrate resistant disease, advances that promise to extend life and perhaps even cure a subset of men with metastatic disease.
With its comprehensive illustrations and contributions from renowned experts in the field, Management of Prostate Cancer, 3rd Edition is an invaluable resource for practitioners in the treatment of prostate cancer.
The updated, revised edition of this acclaimed book offers authoritative guidance on trends in diagnosis and mortality, new PSA isoforms for diagnosis, PSA screening, chemoprevention, biopsy techniques, sural nerve grafting and hereditary prostate cancer.
1?Epidemiology and Risk Factors?
?Ranko Miocinovic
2?Twenty years and counting: is PSA still useful in 2010??
?Haluk Ozen
?Sertac Yazici
3?Prostate Cancer Screening: A Review of the Evidence with Clinical Practice Implications?
?Timothy J Wilt
4?Beyond PSA: Promising New Markers for Prostate Cancer?
?Leonard Marks
5?Hereditary Prostate Cancer and Genetic Risk?
?Adam C Reese
?Graham Casey
?John S Witte
6?Prostate Inflammation and Prostate Cancerl#+